erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Granuloma, Respiratory Tract D015769 1 associated lipids
Staphylococcal Scalded Skin Syndrome D013206 1 associated lipids
Stomatognathic Diseases D009057 1 associated lipids
Moraxellaceae Infections D045828 3 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Fecal Incontinence D005242 1 associated lipids
Atrioventricular Block D054537 1 associated lipids
Abdominal Abscess D018784 2 associated lipids
Vagus Nerve Injuries D061223 1 associated lipids
Pyloric Stenosis, Hypertrophic D046248 2 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Watanabe M et al. Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo. 1999 Xenobiotica pmid:10553724
Zallen RD and Curry JT A study of antibiotic usage in compound mandibular fractures. 1975 J Oral Surg pmid:1055204
Jobe DA et al. Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents. 1999 Clin. Diagn. Lab. Immunol. pmid:10548588
Netherwood T et al. Probiotics shown to change bacterial community structure in the avian gastrointestinal tract. 1999 Appl. Environ. Microbiol. pmid:10543832
Aoki Y and Kao PN Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. 1999 Antimicrob. Agents Chemother. pmid:10543746
Maeda K et al. [A case of common variable immunodeficiency that responded to long-term erythromycin chemotherapy]. 1999 Nihon Kokyuki Gakkai Zasshi pmid:10540836
Tobback K et al. Micellar electrokinetic capillary chromatography of macrolide antibiotics. Separation of tylosin, erythromycin and their related substances. 1999 J Chromatogr A pmid:10536850
Nicholas KC et al. Periadenitis mucosa necrotica recurrens. 1975 J Oral Surg pmid:1053656
Schmidtke LM and Carson J Induction, characterisation and pathogenicity in rainbow trout Oncorhynchus mykiss (Walbaum) of Lactococcus garvieae L-forms. 1999 Vet. Microbiol. pmid:10535774
Janier M [Syphilis (except congenital syphilis)]. 1999 Aug-Sep Ann Dermatol Venereol pmid:10530355
Sato A et al. Effects of organic anions and vinblastine on biliary excretion of erythromycin in rats. 1999 Pharmacology pmid:10529657
Yoh M et al. Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. 1999 Can. J. Microbiol. pmid:10526400
Shortridge VD et al. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. 1999 Clin. Infect. Dis. pmid:10524961
Cocito C and Di Giambattista M The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits. 1978 Mol. Gen. Genet. pmid:105240
Sheu BS et al. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer. 1999 Jul-Aug Hepatogastroenterology pmid:10521999
Xue Q et al. A multiplasmid approach to preparing large libraries of polyketides. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10518520
De Winter BY et al. Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. 1999 Gut pmid:10517907
Yoshida H and Furuta T [Tissue penetration properties of macrolide antibiotics--comparative tissue distribution of erythromycin-stearate, clarithromycin, roxithromycin and azithromycin in rats]. 1999 Jpn J Antibiot pmid:10516929
Chantarotorn S et al. Diffuse panbronchiolitis, the first case reports in Thailand. 1999 J Med Assoc Thai pmid:10511794
Ball SE et al. Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4. 1999 Clin. Pharmacol. Ther. pmid:10511065
Kinirons MT et al. Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. 1999 Clin. Pharmacol. Ther. pmid:10511057
McMullin ST et al. Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. 1999 Arch. Intern. Med. pmid:10510994
Ahmad M et al. Disposition kinetics of erythromycin in normal and experimentally-induced febrile rabbits. 1999 Apr-Jun Eur J Drug Metab Pharmacokinet pmid:10510739
Khan SA et al. Simultaneous detection of erythromycin-resistant methylase genes ermA and ermC from Staphylococcus spp. by multiplex-PCR. 1999 Mol. Cell. Probes pmid:10508560
Oster P et al. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. 1999 Antimicrob. Agents Chemother. pmid:10508033
Miossec-Bartoli C et al. The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells. 1999 Antimicrob. Agents Chemother. pmid:10508024
Rosendal K et al. Staphylococcus aureus strains isolated in Danish hospitals from January 1st, 1966, to December 31st, 1974. 1976 Acta Pathol Microbiol Scand B pmid:1050144
Widdowson CA and Klugman KP Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. 1999 Semin Respir Infect pmid:10501313
Moreno M et al. Clinical management of tacrolimus drug interactions in renal transplant patients. 1999 Transplant. Proc. pmid:10500564
Zgoulli S et al. Microencapsulation of erythromycin and clarithromycin using a spray-drying technique. 1999 Sep-Oct J Microencapsul pmid:10499837
Azuma A and Kudoh S [Diffuse panbronchiolitis: DPB]. 1999 Nippon Rinsho pmid:10497417
Gibson EM et al. Transfer of plasmid-mediated antibiotic resistance from streptococci to lactobacilli. 1979 J. Bacteriol. pmid:104973
Cash P et al. A proteomic analysis of erythromycin resistance in Streptococcus pneumoniae. 1999 Electrophoresis pmid:10493130
Moore PA Dental therapeutic indications for the newer long-acting macrolide antibiotics. 1999 J Am Dent Assoc pmid:10492541
Kirsten D and Meister W [Present possibilities of antibiotic therapy in chronic non-specific respiratory diseases (author's transl)]. 1976 Z Erkr Atmungsorgane pmid:1049185
Wieckiewicz JA Relationship between resistance to metallic ions and production of beta-lactamase in strains of Staphylococcus epidermidis. 1976 J Hyg Epidemiol Microbiol Immunol pmid:1048968
Gómez-Lus R et al. Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens. 1999 J. Clin. Microbiol. pmid:10488213
Sarisuta N et al. Physico-chemical characterization of interactions between erythromycin and various film polymers. 1999 Int J Pharm pmid:10486428
Cizman M et al. Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens. 1999 Eur. J. Clin. Microbiol. Infect. Dis. pmid:10482034
Wilson DJ et al. Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens. 1999 J. Dairy Sci. pmid:10480091
Howard KB et al. Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. 1999 Am J Health Syst Pharm pmid:10478989
Gabriëls M et al. Densitometric thin layer chromatographic analysis of tretinoin and erythromycin in lotions for topical use in acne treatment. 1999 Eur J Pharm Biopharm pmid:10477329
Madinier IM et al. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans. 1999 J. Periodontol. pmid:10476896
Rizzo G et al. [Behavior of Vibrio cholerae strains of the biotype El Tor isolated in Apulia in 1973, in relation to various antibiotics and chemotherapeutics]. 1975 May-Jun Ann Sclavo pmid:1047628
Mikasa K et al. [Clinical application of the new action of macrolide preparations to respiratory diseases]. 1999 Nippon Naika Gakkai Zasshi pmid:10475020
Syphilis: CDC recommended treatment schedules 1976. 1976 Prim. Care pmid:1047450
Sturm A et al. Prokinetics in patients with gastroparesis: a systematic analysis. 1999 Sep-Oct Digestion pmid:10473966
Mikamo H et al. Adequate macrolide treatment schedules for uterine cervicitis caused by Chlamydia trachomatis. 1999 Sep-Oct Chemotherapy pmid:10473928
Sofer D et al. 'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. 1999 Sep-Oct Chemotherapy pmid:10473921
Nawaz MS et al. Biochemical and molecular characterization of erthromycin-resistant avian Staphylococcus spp. isolated from chickens. 1999 Poult. Sci. pmid:10472846
Cross NA et al. Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method. 1999 Antimicrob. Agents Chemother. pmid:10471587
De Azavedo JC et al. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. 1999 Antimicrob. Agents Chemother. pmid:10471555
Huovinen P Causes, diagnosis and treatment of pharyngitis. 1999 Jun-Jul Compr Ther pmid:10470516
Di Lorenzo C et al. Effect of sequential erythromycin and octreotide on antroduodenal manometry. 1999 J. Pediatr. Gastroenterol. Nutr. pmid:10467994
Manners BT et al. An investigation of antibiotic resistance of Staphylococcus aureus in general practice. 1976 Practitioner pmid:1046672
Cerbo M and Vecchione R [L-forms and pigment production in "Pseudomonas aeruginosa" (author's transl)]. 1978 May-Jun Ann Sclavo pmid:104666
Ando M et al. A new look at hypersensitivity pneumonitis. 1999 Curr Opin Pulm Med pmid:10461534
Arpin C et al. Emergence of mefA and mefE genes in beta-haemolytic streptococci and pneumococci in France. 1999 J. Antimicrob. Chemother. pmid:10459823
Luna VA et al. A variety of gram-positive bacteria carry mobile mef genes. 1999 J. Antimicrob. Chemother. pmid:10459806
Odland BA et al. Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe). 1999 Diagn. Microbiol. Infect. Dis. pmid:10459483
Boyanova L et al. Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years. 1999 Diagn. Microbiol. Infect. Dis. pmid:10459482
Watanakunakorn C Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. 1976 Am. J. Med. pmid:1045861
Grunt J and Krcméry V Multiple drug-resistance in staphylococci, an analysis of all-nation computer-processed data. 1976 Zentralbl Bakteriol Orig A pmid:1045837
Morales WJ et al. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. 1999 Am. J. Obstet. Gynecol. pmid:10454674
Tamaoki J et al. Macrolide antibiotics protect against immune complex-induced lung injury in rats: role of nitric oxide from alveolar macrophages. 1999 J. Immunol. pmid:10453038
Wang H et al. Demethylation capacity of human fetal adrenal mitochondrial cytochrome P-450 in vitro. 1999 Zhongguo Yao Li Xue Bao pmid:10452125
Cohen J et al. Mediterranean spotted fever in pregnancy. 1999 Scand. J. Infect. Dis. pmid:10447334
Vorland LH et al. Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus. 1999 Scand. J. Infect. Dis. pmid:10447328
Jones KL et al. The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration. 1999 Am. J. Gastroenterol. pmid:10445530
Moss AJ et al. A review of the cardiac systemic side-effects of antihistamines: ebastine. 1999 Clin. Exp. Allergy pmid:10444238
Schiano P et al. [Gastroparesis of central origin: usefulness of erythromycin]. 1999 Can J Anaesth pmid:10442972
Limia A et al. Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group. 1999 Eur. J. Clin. Microbiol. Infect. Dis. pmid:10442424
Albini E et al. Activity of aerosol thiamphenicol glycinate acetylcysteinate in a mouse model of S. pyogenes pneumonia. 1999 Arzneimittelforschung pmid:10442213
Blackwell BA et al. Oxidative deamination of hydrolyzed fumonisin B(1) (AP(1)) by cultures of Exophiala spinifera. 1999 Nat. Toxins pmid:10441035
Kearney GC et al. Structural elucidation studies of erythromycins by electrospray tandem mass spectrometry II. 1999 Rapid Commun. Mass Spectrom. pmid:10440983
Sakai C et al. Nocardia asteroides pneumonia, subcutaneous abscess and meningitis in a patient with advanced malignant lymphoma: successful treatment based on in vitro antimicrobial susceptibility. 1999 Intern. Med. pmid:10440509
Drug interactions. 1999 Med Lett Drugs Ther pmid:10436770
Kumar A and Will EJ Necrotizing fasciitis and Legionnaires' disease after combined renal and pancreatic transplantation: a penalty of overseas travel. 1999 Nephrol. Dial. Transplant. pmid:10435897
Barone A et al. Microbiotica associated with refractory periodontis. Prevalence and antibiotic susceptibility. 1999 Minerva Stomatol pmid:10434536
Krecic-Shepard ME et al. In vivo comparison of putative probes of CYP3A4/5 activity: erythromycin, dextromethorphan, and verapamil. 1999 Clin. Pharmacol. Ther. pmid:10430108
Credito KL et al. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. 1999 Antimicrob. Agents Chemother. pmid:10428930
Giovanetti E et al. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. 1999 Antimicrob. Agents Chemother. pmid:10428916
Johnson MM et al. Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. 1999 Antimicrob. Agents Chemother. pmid:10428903
Callréus T et al. Changes in gastrointestinal motility influence the absorption of desmopressin. 1999 Eur. J. Clin. Pharmacol. pmid:10424324
Bachmann K et al. A study of the interaction between dirithromycin and astemizole in healthy adults. 1997 Feb-Mar Am J Ther pmid:10423595
Okada J et al. [Changes of antimicrobial susceptibility of anaerobic bacteria from clinical specimens (author's transl)]. 1975 Jpn J Antibiot pmid:1042183
Cvetkovic M et al. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. 1999 Drug Metab. Dispos. pmid:10421612
Latorre G et al. [Chlamydia pneumoniae pneumonia]. 1998 Jan-Mar Rev Med Univ Navarra pmid:10420952
de Sousa G et al. A multi-laboratory evaluation of cryopreserved monkey hepatocyte functions for use in pharmaco-toxicology. 1999 Chem. Biol. Interact. pmid:10418972
Kearney JA et al. In vitro activities of the oxazolidinone compounds linezolid (PNU-100766) and eperzolid (PNU-100592) against middle ear isolates of Streptococcus pneumoniae. 1999 Int. J. Antimicrob. Agents pmid:10418759
Albini E et al. In vitro antibacterial activity of thiamphenicol glycinate acetylcysteinate against respiratory pathogens. 1999 Arzneimittelforschung pmid:10417871
Lee DO and Lee CD Serotonin syndrome in a child associated with erythromycin and sertraline. 1999 Pharmacotherapy pmid:10417041
Matsumoto H et al. Sensitivity of fresh isolates of Haemophilus to current antibiotics. 1975 Jpn J Antibiot pmid:1041598
Finegold SM Antimicrobial therapy of anaerobic infections. 1975 Postgrad Med pmid:1041514
Driessen JH A computer study of bacterial resistance patterns to antibiotics. 1975 Chemotherapy pmid:1041490
Lin CF and Chung TC Cloning of erythromycin-resistance determinants and replication origins from indigenous plasmids of Lactobacillus reuteri for potential use in construction of cloning vectors. 1999 Plasmid pmid:10413663
Wagenvoort JH et al. How useful is the Chlamydia micro-immunofluorescence (MIF) test for the gynaecologist? 1999 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:10413220
Drici MD et al. Comparison of tegaserod (HTF 919) and its main human metabolite with cisapride and erythromycin on cardiac repolarization in the isolated rabbit heart. 1999 J. Cardiovasc. Pharmacol. pmid:10413072
Messini M et al. Bacteremia after dental treatment in mentally handicapped people. 1999 J. Clin. Periodontol. pmid:10412852
Oguri T et al. [Multiple drug resistance of Enterobacter-Serratia group isolated from clinical materials (author's transl)]. 1975 Jpn J Antibiot pmid:1041281